Genomic Vision Société Anonyme reported unaudited sales results for the first half ended June 30, 2022. Revenue from sales for the first half of 2022 amounted to €511,000, up 9.4% compared to €467,000 the first half of 2021. This increase in sales of products and services reflects the efforts made in commercial prospecting.

It should be noted that no platform sales were made during the first half of the year. Total revenue from activity in the first half of 2022, after taking into account other revenue, is up by 5.8% compared to the same period in 2021. Other income, amounting to €232,000 in the first half of 2022, corresponds to the research tax credit.

Total revenue from activity was €743,000 against €702,000 a year ago.